Emily Moran, senior vice-president of vector manufacturing and supply chain at The Center for Breakthrough Medicines, talks about manufacturing processes for viral vectors in the cell and gene therapy space, and more.
Emily Moran, senior vice-president of vector manufacturing and supply chain at The Center for Breakthrough Medicines, talks about manufacturing processes for viral vectors in the cell and gene therapy space. She also discusses complications and standardizations in manufacturing processes, as well as how automation and digitalization may impact the future of cell and gene therapies.
For more INTERPHEX 2023 video content, check this page for updates.
How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)
November 29th 2022Allison Labriola, Senior Technical Sales Representative, at JRS Pharma is interviewed by the Editorial Director of Pharmaceutical Technology Chris Spivey about how the food industry is affecting the pharmaceutical industry.
AAPS PharmSci 360 2024: Predictive Models for Poorly Soluble Drugs
October 10th 2024Pharmaceutical Technology sat down with Niloufar Salehi, advisor at Eli Lilly & Company, to talk about the session she is moderating at AAPS PharmSci 360 2024, Symposium: An Accelerated Development of Poorly Soluble Drugs Using Predictive Tool.